One group has demonstrated that restoring the ability of immunotolerant leukocytes to mount a glycolytic response by treatment with IFN‐γ leads to an increased cytokine production and might represent a promising novel therapeutic approach to revert the immunotolerant state of sepsis (Cheng et al, 2016). The gene discussed is IFNG; the disease is Sepsis.